logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Extrawell Pharmaceutical (00858.HK) appoints Wu Xiangyun as executive director

date
12/10/2026
Zhito Finance APP News: Extrawell Pharmaceutical (00858.HK) announced that Mr. Wu Xiangyun has been appointed as an executive director of the Company, effective from October 12, 2026.
Latest
9 m ago
The U.S. Department of State issued a joint statement endorsing the United Kingdom's determination of Iran's responsibility for its involvement in the attempted terrorist attack on Royal Air Force Fairford.
10 m ago
Turkish President Erdogan: Turkey condemns in the strongest terms the Houthi attack on Saudi Arabia.
11 m ago
Turkish President Erdogan: After the Houthi attack on Saudi airports, Turkey firmly supports Saudi Arabia.
11 m ago
U.S. Treasury yields surge hits the mortgage-backed securities market. U.S. MBS funds post historic outflows for three consecutive weeks.
12 m ago
Goldman Sachs: $1.7 trillion buyback wave will cushion the impact of a surge in equity supply.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.